Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Socioeconomic gradient in use of statins among Danish patients: population‐based cross‐sectional study

Socioeconomic gradient in use of statins among Danish patients: population‐based cross‐sectional... Aims Socioeconomic inequalities in statin use are a public health concern but they may also confound observational studies of statins’ effectiveness. We conducted a population‐based cross‐sectional study in Denmark to examine the association between socioeconomic status (SES) and statin use. Methods We obtained data on socioeconomic status of all persons in North Jutland County, Denmark, between 1995 and 1999 from the Prevention Registry at Statistics Denmark. Data on filled statin prescriptions were identified through the County Prescription Database. We compared the 1‐year prevalence proportions of statin use for different socioeconomic groups, adjusted for age and urbanization. Separate analyses were done for patients with a history of cardiovascular disease as recorded in the County Hospital Discharge Registry. Results Among men with cardiovascular disease, statin use in 1995 was higher in those with the highest socioeconomic status (adjusted relative prevalence proportion (RPP) among top managers 1.86, 95% CI: 1.17–2.96), and lower among retired men (RPP (95% CI) 0.63 (0.43–0.93) in old‐age pensioners, and 0.66 (0.45–0.98) in the early retired), when compared with basic‐level workers. The socioeconomic differences in statin use among men decreased in magnitude over time but remained throughout the study period. We found no clear social gradient in statin use among women. Conclusions Even in a health care system that claims to ensure a high degree of equity in medical care, we found clear indications of a socioeconomic gradient in statin use among men in the years after the launching of these drugs. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png British Journal of Clinical Pharmacology Wiley

Socioeconomic gradient in use of statins among Danish patients: population‐based cross‐sectional study

Download PDF
9 pages

Loading next page...
 
/lp/wiley/socioeconomic-gradient-in-use-of-statins-among-danish-patients-P002dbI27j

References (48)

Publisher
Wiley
Copyright
Copyright © 2005 Wiley Subscription Services, Inc., A Wiley Company
ISSN
0306-5251
eISSN
1365-2125
DOI
10.1111/j.1365-2125.2005.02494.x
pmid
16236044
Publisher site
See Article on Publisher Site

Abstract

Aims Socioeconomic inequalities in statin use are a public health concern but they may also confound observational studies of statins’ effectiveness. We conducted a population‐based cross‐sectional study in Denmark to examine the association between socioeconomic status (SES) and statin use. Methods We obtained data on socioeconomic status of all persons in North Jutland County, Denmark, between 1995 and 1999 from the Prevention Registry at Statistics Denmark. Data on filled statin prescriptions were identified through the County Prescription Database. We compared the 1‐year prevalence proportions of statin use for different socioeconomic groups, adjusted for age and urbanization. Separate analyses were done for patients with a history of cardiovascular disease as recorded in the County Hospital Discharge Registry. Results Among men with cardiovascular disease, statin use in 1995 was higher in those with the highest socioeconomic status (adjusted relative prevalence proportion (RPP) among top managers 1.86, 95% CI: 1.17–2.96), and lower among retired men (RPP (95% CI) 0.63 (0.43–0.93) in old‐age pensioners, and 0.66 (0.45–0.98) in the early retired), when compared with basic‐level workers. The socioeconomic differences in statin use among men decreased in magnitude over time but remained throughout the study period. We found no clear social gradient in statin use among women. Conclusions Even in a health care system that claims to ensure a high degree of equity in medical care, we found clear indications of a socioeconomic gradient in statin use among men in the years after the launching of these drugs.

Journal

British Journal of Clinical Pharmacology – Wiley

Published: Nov 1, 2005

There are no references for this article.